---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-013070"
form_type: "8-K"
ticker: "LSTA"
cik: "0000320017"
company_name: "LISATA THERAPEUTICS, INC."
filed_at: "2026-04-03T23:59:59+00:00"
generated_at: "2026-05-15T07:43:58.928695+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Lisata extends tender offer deadline to April 13, 2026 per waiver

## Summary
- Deadline to commence tender offer moved from April 3 to April 13, 2026.
- Waiver signed April 2 by Lisata, Kuva Labs Inc., and Kuva Acquisition Corp.
- All other Merger Agreement terms (March 6, 2026) remain unchanged.

## SEC filing metadata
- accession: 0001140361-26-013070
- form_type: 8-K
- ticker: LSTA
- cik: 0000320017
- company_name: LISATA THERAPEUTICS, INC.
- filed_at: 2026-04-03T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/320017/000114036126013070/0001140361-26-013070-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/320017/000114036126013070/ef20069819_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-013070
- JSON: https://secwatch.observer/filing/0001140361-26-013070.json
- Plain text: https://secwatch.observer/filing/0001140361-26-013070.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.